Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription

Virology

Volumn 403, Issue 1, 2010, Pages 56-66

  Hoenen, T ^a   Jung, S ^a   Herwig, A ^a   Groseth, A ^a   Becker, S ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Ebola; Filovirus; Matrix protein; Minigenome; Regulation; Replication; Replication deficient minigenome; Transcription; VP24; VP40

Indexed keywords

MATRIX PROTEIN; PROTEIN VP24; PROTEIN VP40; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EBOLA VIRUS; GENE REPLICATION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; VIRUS GENOME;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; EBOLAVIRUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; GENES, REPORTER; HUMANS; LUCIFERASES; NUCLEOPROTEINS; RNA, VIRAL; TRANSCRIPTION, GENETIC; VIRAL CORE PROTEINS; VIRAL PROTEINS;

EBOLA VIRUS; MARBURGVIRUS; PRIMATES;

EID: 77953287302     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.04.002     Document Type: Article

References (63)

1. Bamberg S., Kolesnikova L., Moller P., Klenk H.D., Becker S. VP24 of Marburg virus influences the formation of infectious particles. J. Virol. 2005, 79(21):13421-13433.
2. Banerjee A.K., Barik S., De B.P. Gene expression of nonsegmented negative strand RNA viruses. Pharmacol. Ther. 1991, 51(1):47-70.
3. Black B.L., Lyles D.S. Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J. Virol. 1992, 66(7):4058-4064.
4. Bunte T., Novak U., Friedrich R., Moelling K. Effect of actinomycin D on nucleic acid hybridization: the cause of erroneous DNA elongation during DNA synthesis of RNA tumor viruses in vitro. Biochim. Biophys. Acta 1980, 610(2):241-247.
5. Calain P., Monroe M.C., Nichol S.T. Ebola virus defective interfering particles and persistent infection. Virology 1999, 262(1):114-128.
6. Carroll A.R., Wagner R.R. Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus. J. Virol. 1979, 29(1):134-142.
7. Chiou P.P., Kim C.H., Ormonde P., Leong J.A. Infectious hematopoietic necrosis virus matrix protein inhibits host-directed gene expression and induces morphological changes of apoptosis in cell cultures. J. Virol. 2000, 74(16):7619-7627.
8. Clinton G.M., Little S.P., Hagen F.S., Huang A.S. The matrix (M) protein of vesicular stomatitis virus regulates transcription. Cell 1978, 15(4):1455-1462.
9. Conzelmann K.K. Reverse genetics of mononegavirales. Curr. Top. Microbiol. Immunol. 2004, 283:1-41.
10. De B.P., Thornton G.B., Luk D., Banerjee A.K. Purified matrix protein of vesicular stomatitis virus blocks viral transcription in vitro. Proc. Natl. Acad. Sci. U. S. A. 1982, 79(23):7137-7141.
11. Ebihara H., Groseth A., Neumann G., Kawaoka Y., Feldmann H. The role of reverse genetics systems in studying viral hemorrhagic fevers. Thromb. Haemost. 2005, 94:240-253.
12. Enterlein S., Schmidt K.M., Schumann M., Conrad D., Krahling V., Olejnik J., Muhlberger E. The Marburg virus 3' noncoding region structurally and functionally differs from that of Ebola virus. J. Virol. 2009, 83(9):4508-4519.
13. Finke S., Conzelmann K.K. Dissociation of rabies virus matrix protein functions in regulation of viral RNA synthesis and virus assembly. J. Virol. 2003, 77(22):12074-12082.
14. Finke S., Mueller-Waldeck R., Conzelmann K.K. Rabies virus matrix protein regulates the balance of virus transcription and replication. J. Gen. Virol. 2003, 84(Pt 6):1613-1621.
15. Gene O.G., Julia B.E., Vanessa M.R., Victoria W.J., Thomas G.W., Lisa H.E. Drug targets in infections with Ebola and Marburg viruses. Infect. Disord. Drug Targets 2009, 9(2):191-200.
16. Gomis-Ruth F.X., Dessen A., Timmins J., Bracher A., Kolesnikowa L., Becker S., Klenk H.D., Weissenhorn W. The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties. Structure (Camb) 2003, 11(4):423-433.
17. Groseth A., Feldmann H., Theriault S., Mehmetoglu G., Flick R. RNA polymerase I-driven minigenome system for Ebola viruses. J. Virol. 2005, 79(7):4425-4433.
18. Groseth A., Hoenen T., Alimonti J.B., Zielecki F., Ebihara H., Theriault S., Stroher U., Becker S., Feldmann H. In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics. J. Infect. Dis. 2007, 196(Suppl 2):S382-S389.
19. Hartlieb B., Modrof J., Muhlberger E., Klenk H.D., Becker S. Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide. J. Biol. Chem. 2003, 278(43):41830-41836.
20. Hass M., Golnitz U., Muller S., Becker-Ziaja B., Gunther S. Replicon system for Lassa virus. J. Virol. 2004, 78(24):13793-13803.
21. Hoenen T., Volchkov V., Kolesnikova L., Mittler E., Timmins J., Ottmann M., Reynard O., Becker S., Weissenhorn W. VP40 octamers are essential for Ebola virus replication. J. Virol. 2005, 79(3):1898-1905.
22. Hoenen T., Groseth A., Kolesnikova L., Theriault S., Ebihara H., Hartlieb B., Bamberg S., Stroher U., Feldmann H., Becker S. Infection of naive target cells with virus-like particles-implications for the function of Ebola virus VP24. J. Virol. 2006, 80(14):7260-7264.
23. Hoenen T., Kolesnikova L., Becker S. Recent advances in filovirus- and arenavirus-like particles. Future Virol. 2007, 2(2):193-203.
24. Huang Y., Xu L., Sun Y., Nabel G.J. The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. Mol. Cell 2002, 10(2):307-316.
25. Hurley L.H. DNA and its associated processes as targets for cancer therapy. Nat. Rev. Cancer 2002, 2(3):188-200.
26. Iwasaki M., Takeda M., Shirogane Y., Nakatsu Y., Nakamura T., Yanagi Y. The matrix protein of measles virus regulates viral RNA synthesis and assembly by interacting with the nucleocapsid protein. J. Virol. 2009, 83(20):10374-10383.
27. Jacamo R., Lopez N., Wilda M., Franze-Fernandez M.T. Tacaribe virus Z protein interacts with the L polymerase protein to inhibit viral RNA synthesis. J. Virol. 2003, 77(19):10383-10393.
28. Jeeninga R.E., Huthoff H.T., Gultyaev A.P., Berkhout B. The mechanism of actinomycin D-mediated inhibition of HIV-1 reverse transcription. Nucleic Acids Res. 1998, 26(23):5472-5479.
29. Johnson R.F., Bell P., Harty R.N. Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology. Virol. J. 2006, 3:31.
30. Kang H.J., Park H.J. Novel molecular mechanism for actinomycin D activity as an oncogenic promoter G-quadruplex binder. Biochemistry 2009, 48(31):7392-7398.
31. Kobasa D., Rodgers M.E., Wells K., Kawaoka Y. Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks. J. Virol. 1997, 71(9):6706-6713.
32. Lopez N., Jacamo R., Franze-Fernandez M.T. Transcription and RNA replication of tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes. J. Virol. 2001, 75(24):12241-12251.
33. Martinez M.J., Biedenkopf N., Volchkova V., Hartlieb B., Alazard-Dany N., Reynard O., Becker S., Volchkov V. Role of Ebola virus VP30 in transcription reinitiation. J. Virol. 2008, 82(24):12569-12573.
34. Modrof J., Muhlberger E., Klenk H.D., Becker S. Phosphorylation of VP30 impairs Ebola virus transcription. J. Biol. Chem. 2002, 277(36):33099-33104.
35. Muhlberger E. Filovirus replication and transcription. Future Virol. 2007, 2(2):205-215.
36. Muhlberger E., Sanchez A., Randolf A., Will C., Kiley M.P., Klenk H.D., Feldmann H. The nucleotide sequence of the L gene of Marburg virus, a filovirus: homologies with paramyxoviruses and rhabdoviruses. Virology 1992, 187(2):534-547.
37. Muhlberger E., Lotfering B., Klenk H.D., Becker S. Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes. J. Virol. 1998, 72(11):8756-8764.
38. Muhlberger E., Weik M., Volchkov V.E., Klenk H.D., Becker S. Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems. J. Virol. 1999, 73(3):2333-2342.
39. Neumann G., Brownlee G.G., Fodor E., Kawaoka Y. Orthomyxovirus replication, transcription, and polyadenylation. Curr. Top. Microbiol. Immunol. 2004, 283:121-143.
40. Neumann G., Ebihara H., Takada A., Noda T., Kobasa D., Jasenosky L.D., Watanabe S., Kim J.H., Feldmann H., Kawaoka Y. Ebola virus VP40 late domains are not essential for viral replication in cell culture. J. Virol. 2005, 79(16):10300-10307.
41. Neumann P., Lieber D., Meyer S., Dautel P., Kerth A., Kraus I., Garten W., Stubbs M.T. Crystal structure of the Borna disease virus matrix protein (BDV-M) reveals ssRNA binding properties. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(10):3710-3715.
42. Nguyen V.T., Giannoni F., Dubois M.F., Seo S.J., Vigneron M., Kedinger C., Bensaude O. In vivo degradation of RNA polymerase II largest subunit triggered by alpha-amanitin. Nucleic Acids Res. 1996, 24(15):2924-2929.
43. Niles A.L., Moravec R.A., Eric Hesselberth P., Scurria M.A., Daily W.J., Riss T.L. A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers. Anal. Biochem. 2007, 366(2):197-206.
44. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108(2):193-199.
45. Noda T., Ebihara H., Muramoto Y., Fujii K., Takada A., Sagara H., Kim J.H., Kida H., Feldmann H., Kawaoka Y. Assembly and budding of Ebolavirus. PLoS Pathog. 2006, 2(9):e99.
46. Noda T., Watanabe S., Sagara H., Kawaoka Y. Mapping of the VP40-binding regions of the nucleoprotein of Ebola virus. J. Virol. 2007, 81(7):3554-3562.
47. Pattnaik A.K., Ball L.A., LeGrone A.W., Wertz G.W. Infectious defective interfering particles of VSV from transcripts of a cDNA clone. Cell 1992, 69(6):1011-1020.
48. Pattnaik A.K., Hwang L., Li T., Englund N., Mathur M., Das T., Banerjee A.K. Phosphorylation within the amino-terminal acidic domain I of the phosphoprotein of vesicular stomatitis virus is required for transcription but not for replication. J. Virol. 1997, 71(11):8167-8175.
49. Peeples M.E., Collins P.L. Mutations in the 5' trailer region of a respiratory syncytial virus minigenome which limit RNA replication to one step. J. Virol. 2000, 74(1):146-155.
50. Saikia P., Gopinath M., Shaila M.S. Phosphorylation status of the phosphoprotein P of rinderpest virus modulates transcription and replication of the genome. Arch. Virol. 2008, 153(4):615-626.
51. Sanchez A., Geisbert T., Feldmann H. Filoviridae-Marburg and Ebola viruses. Fields Virology 2007, vol. 1:1410-1448. Lippincott Williams and Wilkins, Philadelphia, PA. 5 ed. D. Knipe (Ed.).
52. Scamrov A.V., Beabealashvilli R.S. Binding of actinomycin D to DNA revealed by DNase I footprinting. FEBS Lett. 1983, 164(1):97-101.
53. Taylor A., Easton A.J., Marriott A.C. Matrix protein of Chandipura virus inhibits transcription from an RNA polymerase II promoter. Virus Genes 1999, 19(3):223-228.
54. Wadkins R.M., Vladu B., Tung C.S. Actinomycin D binds to metastable hairpins in single-stranded DNA. Biochemistry 1998, 37(34):11915-11923.
55. Watanabe K., Handa H., Mizumoto K., Nagata K. Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein. J. Virol. 1996, 70(1):241-247.
56. Watanabe S., Watanabe T., Noda T., Takada A., Feldmann H., Jasenosky L.D., Kawaoka Y. Production of novel Ebola virus-like particles from cDNAs: an alternative to Ebola virus generation by reverse genetics. J. Virol. 2004, 78(2):999-1005.
57. Watanabe S., Noda T., Kawaoka Y. Functional mapping of the nucleoprotein of Ebola virus. J. Virol. 2006, 80(8):3743-3751.
58. Watanabe S., Noda T., Halfmann P., Jasenosky L., Kawaoka Y. Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome. J. Infect. Dis. 2007, 196(Suppl 2):S284-S290.
59. Weik M., Modrof J., Klenk H.D., Becker S., Muhlberger E. Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J. Virol. 2002, 76(17):8532-8539.
60. Weik M., Enterlein S., Schlenz K., Muhlberger E. The Ebola virus genomic replication promoter is bipartite and follows the rule of six. J. Virol. 2005, 79(16):10660-10671.
61. Wenigenrath, J., Kolesnikova, L., Hoenen, T., Mittler, E., and Becker, S., 2010. Establishment and application of an infectious virus-like particle system for Marburg Virus. J. Gen. Virol. 93, 1325-1334.
62. Whelan S.P., Barr J.N., Wertz G.W. Transcription and replication of nonsegmented negative-strand RNA viruses. Curr. Top. Microbiol. Immunol. 2004, 283:61-119.
63. Yoo H., Rill R.L. Actinomycin D binding to unstructured, single-stranded DNA. J. Mol. Recognit. 2001, 14(3):145-150.